2021 CDER Report: New Approvals Improve Patient Treatment Options

The Center for Drug Evaluation and Research (CDER) has released a new report detailing the 60 drugs the FDA approved in 2021. Over half of these drugs were first-in-class and offer novel treatment options for several conditions, including lupus nephritis, heart failure, and HIV. The Center for Biologics Evaluation and Research approved 10 of the 60 drugs, the remainder approved by the CDER.

According to Richard Moscicki, MD, “At CBER, five new approved vaccines, including the first FDA-approved COVID-19 occurred in 2021, as well as two new CAR-T cell therapies for certain types of multiple myeloma and lymphoma. CAR-T cell therapies represent a game-changing approach involving permanently altering a patient’s T-cells to recognize, target and kill cancer cells.”

Read more by clicking here.

(Source: PhRMA, January 26^th, 2022)